Clinical and immunohistochemical effects of OncoTherad (MRB-CFI-1) nanoimmunotherapy on SERBP1, HABP4, CD44 and Ki-67 in BCG-unresponsive non-muscle invasive bladder cancer.
第一单位:
Laboratory of Urogenital Carcinogenesis and Immunotherapy (LCURGIN), Universidade Estadual de Campinas (UNICAMP), Campinas City, São Paulo State, Brazil.
作者:
医学主题词
人类(Humans);膀胱肿瘤(Urinary Bladder Neoplasms);女(雌)性(Female);男(雄)性(Male);老年人(Aged);免疫疗法(Immunotherapy);Ki-67抗原(Ki-67 Antigen);中年人(Middle Aged);卡介苗(BCG Vaccine);回顾性研究(Retrospective Studies);免疫组织化学(Immunohistochemistry);肿瘤侵润(Neoplasm Invasiveness);老年人, 80以上(Aged, 80 and over)
DOI
10.1016/j.tice.2025.102783
PMID
39938427
发布时间
2025-05-07
- 浏览1
Tissue & cell
102783页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



